Targeting PAM50 HER2-Enriched Intrinsic Subtype with Enzalutamide in Hormone Receptor- Positive/her2-Negative (HR+/HER2-) Advanced Breast Cancer: Results of the SOLTI-1502 ARIANNA Trial
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined